PT  - JOURNAL ARTICLE
AU  - Sara S.  McCoy
AU  - Christie M.  Bartels
AU  - Ian J.  Saldanha
AU  - Vatinee Y.  Bunya
AU  - Esen K.  Akpek
AU  - Matthew A.  Makara
AU  - Alan N.  Baer
TI  - National Sjögren’s Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life
AID  - 10.3899/jrheum.200733
DP  - 2020 Sep 15
TA  - The Journal of Rheumatology
PG  - jrheum.200733
4099  - http://www.jrheum.org/content/early/2021/04/10/jrheum.200733.short
4100  - http://www.jrheum.org/content/early/2021/04/10/jrheum.200733.full
AB  - Objective To define the association between oral and systemic manifestations of Sjögren syndrome (SS) and quality of life (QOL). Methods We analyzed a cross-sectional survey conducted by the Sjögren’s Foundation in 2016, with 2961 eligible responses. We defined oral symptom and sign exposures as parotid gland swelling, dry mouth, mouth ulcers/sores, oral candidiasis, trouble speaking, choking or dysphagia, sialolithiasis or gland infection, and dental caries. Systemic exposures included interstitial lung disease, purpura/petechiae/cryoglobulinemia, vasculitis, neuropathy, leukopenia, interstitial nephritis, renal tubular acidosis, autoimmune hepatitis, primary biliary cholangitis, or lymphoma. Outcomes included SS-specific QOL questions generated by SS experts and patients. Results Using multivariable regression models adjusted for age, sex, race, and employment, we observed that mouth ulcers or sores, trouble speaking, and dysphagia were associated with poor quality of life. The following oral aspects had the greatest effect on the following QOL areas: (1) mouth ulcers/sores on the challenge and burden of living with SS (OR 4.26, 95% CI 2.89–6.28); (2) trouble speaking on memory and concentration (OR 4.24, 95% CI 3.28–5.48); and (3) dysphagia on functional interference (OR 4.25, 95% CI 3.13–5.79). In contrast, systemic manifestations were associated with QOL to a lesser extent or not at all. Conclusion Oral manifestations of SS, particularly mouth ulcers or sores, trouble speaking, and dysphagia, were strongly associated with worse QOL. Further study and targeted treatment of these oral manifestations provides the opportunity to improve quality of life in patients with SS.